Fulphila 6 mg/.6mL
pegfilgrastim-jmdb · INJECTION · Biocon Biologics Inc.
No Recall History
Plain English
Fulphila is a injection containing pegfilgrastim-jmdb at 6 mg/.6mL, taken subcutaneous. Manufactured by Biocon Biologics Inc..
Key Facts
- Brand Name
- Fulphila
- Generic Name
- pegfilgrastim-jmdb
- NDC Code (Product)
83257-005- Manufacturer
- Biocon Biologics Inc.
- Strength
- 6 mg/.6mL
- Dosage Form
- INJECTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- BLA761075
- Drug Class
- Leukocyte Growth Factor [EPC]
- Marketing Start
- 10/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Fulphila used for?
Fulphila contains pegfilgrastim-jmdb. It is a injection taken subcutaneous. Consult your doctor for specific uses.
Is Fulphila a controlled substance?
Fulphila is not classified as a controlled substance by the DEA.
What is the generic name for Fulphila?
The generic name for Fulphila is pegfilgrastim-jmdb. There are no other listed brand versions of pegfilgrastim-jmdb.
What is the NDC code for Fulphila 6 mg/.6mL?
The NDC (National Drug Code) for Fulphila 6 mg/.6mL is 83257-005, listed by Biocon Biologics Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)